Symposium 4: Pragmatic Approaches to Improvements in Pediatric Drug Therapy

Monday September 14, 1300-1400 (UTC)

Geert 't Jong, Children’s Hospital Research Institute of Manitoba (CHRIM), Canada
Michael Rieder, University of Western Ontario, Canada
Catherine M Sherwin, Wright State University Boonshoft School of Medicine Dayton Children’s Hospital, USA

Learning Objectives: At the end of this session participants will be able to:
- Discuss novel methods for drug dose estimation in infants and children based on pre-clinical and adult data and how to effectively communicate this knowledge to researchers, health care providers and patients and their families.
- Discuss the regulatory initiatives taken in the US, Canada, and the EU, and how they enhance the development of appropriate drugs and formulation through legislation and funding opportunities.
- Assess partnership with industry to promote commercialization of pediatric formulations.

Question Title

* 1. This session overall

	Disagree	Neutral	Agree	Strongly Agree
Sufficient time was allowed for audience participation/active learning	Sufficient time was allowed for audience participation/active learning Disagree	Sufficient time was allowed for audience participation/active learning Neutral	Sufficient time was allowed for audience participation/active learning Agree	Sufficient time was allowed for audience participation/active learning Strongly Agree
The session was free from commercial bias	The session was free from commercial bias Disagree	The session was free from commercial bias Neutral	The session was free from commercial bias Agree	The session was free from commercial bias Strongly Agree

Comments:

Question Title

* 2. Overall, I would rate this symposium as:

Fair

Good

Excellent

Comments

Question Title

* 3. Speaker: Geert 't Jong

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

* 4. Speaker: Michael Rieder

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

* 5. Speaker: Catherine Sherwin

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

* 6. As a result of attending this session, I am planning to:

a) Discuss the session with my colleagues.

b) Pursue additional learning activities.

c) Create/revise protocols, policies, and/or procedures.

d) Not change my practice.

Symposium 4: Pragmatic Approaches to Improvements in Pediatric Drug Therapy

Monday September 14, 1300-1400 (UTC)

Question Title

* 1. This session overall

Question Title

* 2. Overall, I would rate this symposium as:

Question Title

* 3. Speaker: Geert 't Jong

Question Title

* 4. Speaker: Michael Rieder

Question Title

* 5. Speaker: Catherine Sherwin

Question Title

* 6. As a result of attending this session, I am planning to:

Question Title

* 7. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

* 8. What topics would you like to be addressed at future conferences to keep you up to date in your profession?